Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008) A. Xhaard, F. Lanternier, R. Porcher, E. Dannaoui, A. Bergeron, L. Clement, C. Lacroix, R. Herbrecht, F. Legrand, M. Mohty, M. Michallet, C. Cordonnier, S. Malak, D. Guyotat, LJ. Couderc, G. Socié, N. Milpied, O. Lortholary, P. Ribaud Clinical Microbiology and Infection Volume 18, Issue 10, Pages E396-E400 (October 2012) DOI: 10.1111/j.1469-0691.2012.03908.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1. (a) Overall survival from mucormycosis diagnosis. The grey-shaded area represents the pointwise 95% confident interval. (b) Overall and mucormycosis-attributable mortality. Clinical Microbiology and Infection 2012 18, E396-E400DOI: (10.1111/j.1469-0691.2012.03908.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions